Wordt geladen...
Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial
SCOPE: Xanthohumol, a prenylflavonoid from hops, has been extensively studied preclinically but has undergone limited research in human subjects. A triple-masked, placebo-controlled phase I clinical trial was conducted to examine the safety and tolerability of xanthohumol. METHODS AND RESULTS: Thirt...
Bewaard in:
| Gepubliceerd in: | Mol Nutr Food Res |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221389/ https://ncbi.nlm.nih.gov/pubmed/33629812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mnfr.202001170 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|